60 related articles for article (PubMed ID: 31668790)
1. Prognostic importance of
Kanyilmaz G; Benli Yavuz B; Aktan M; Sahin O
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):20-26. PubMed ID: 31668790
[TBL] [Abstract][Full Text] [Related]
2. Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.
Zhang P; Chen W; Zhao K; Qiu X; Li T; Zhu X; Sun P; Wang C; Song Y
BMC Med Imaging; 2023 Aug; 23(1):107. PubMed ID: 37582701
[TBL] [Abstract][Full Text] [Related]
3. Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.
Markovina S; Duan F; Snyder BS; Siegel BA; Machtay M; Bradley JD
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):597-605. PubMed ID: 26461002
[TBL] [Abstract][Full Text] [Related]
4. Impact of FDG PET Standardized Uptake Value in Resected Clinical Stage IA Non-Small Cell Lung Cancer.
Tapias LF; Shen R; Cassivi SD; Reisenauer JS; Lunn BW; Lechtenberg BJ; Nichols FC; Wigle DA; Blackmon SH
Ann Thorac Surg; 2024 May; 117(5):1017-1023. PubMed ID: 37080373
[TBL] [Abstract][Full Text] [Related]
5. [
Cegla P; Currie GM; Cholewinski W; Bryl M; Trojanowski M; Matuszewski K; Piotrowski T; Czepczyński R
Radiography (Lond); 2024 May; 30(3):971-977. PubMed ID: 38663216
[TBL] [Abstract][Full Text] [Related]
6. Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
Soldath P; Binderup T; Kjaer A; Knigge U; Langer SW; Petersen RH
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38305412
[TBL] [Abstract][Full Text] [Related]
7. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients.
Ohno Y; Yui M; Yamamoto K; Takenaka D; Koyama H; Nagata H; Ueda T; Ikeda H; Ozawa Y; Toyama H; Yoshikawa T
J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of primary tumor SUV
Yılmaz U; Batum Ö; Koparal H; Özbilek E; Kıraklı E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018 Mar; ():. PubMed ID: 29559214
[TBL] [Abstract][Full Text] [Related]
9. Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.
Bazan JG; Duan F; Snyder BS; Horng D; Graves EE; Siegel BA; Machtay M; Loo BW
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):17-24. PubMed ID: 27645692
[TBL] [Abstract][Full Text] [Related]
10. Discovery of pre-therapy 2-deoxy-2-
Arshad MA; Thornton A; Lu H; Tam H; Wallitt K; Rodgers N; Scarsbrook A; McDermott G; Cook GJ; Landau D; Chua S; O'Connor R; Dickson J; Power DA; Barwick TD; Rockall A; Aboagye EO
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):455-466. PubMed ID: 30173391
[TBL] [Abstract][Full Text] [Related]
11. Preoperative nomogram for predicting spread through air spaces in clinical-stage IA non-small cell lung cancer using
Wang Y; Lyu D; Cheng C; Zhou T; Tu W; Xiao Y; Zuo C; Fan L; Liu S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):185. PubMed ID: 38598007
[TBL] [Abstract][Full Text] [Related]
12. Metabolic patterns on [
Holzgreve A; Taugner J; Käsmann L; Müller P; Tufman A; Reinmuth N; Li M; Winkelmann M; Unterrainer LM; Nieto AE; Bartenstein P; Kunz WG; Ricke J; Belka C; Eze C; Unterrainer M; Manapov F
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2466-2476. PubMed ID: 36951991
[TBL] [Abstract][Full Text] [Related]
13. Promising Candidate Prognostic Biomarkers in [
Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
[TBL] [Abstract][Full Text] [Related]
14. Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.
Finkle JH; Jo SY; Ferguson MK; Liu HY; Zhang C; Zhu X; Yuan C; Pu Y
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1275-1284. PubMed ID: 28265739
[TBL] [Abstract][Full Text] [Related]
15. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.
Thor M; Fitzgerald K; Apte A; Oh JH; Iyer A; Odiase O; Nadeem S; Yorke ED; Chaft J; Wu AJ; Offin M; Simone Ii CB; Preeshagul I; Gelblum DY; Gomez D; Deasy JO; Rimner A
Radiother Oncol; 2024 Jan; 190():109983. PubMed ID: 37926331
[TBL] [Abstract][Full Text] [Related]
16. Deep segmentation networks predict survival of non-small cell lung cancer.
Baek S; He Y; Allen BG; Buatti JM; Smith BJ; Tong L; Sun Z; Wu J; Diehn M; Loo BW; Plichta KA; Seyedin SN; Gannon M; Cabel KR; Kim Y; Wu X
Sci Rep; 2019 Nov; 9(1):17286. PubMed ID: 31754135
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.
Takagi H; Sakamoto J; Osaka Y; Shibata T; Fujita S; Sasagawa T
Medicine (Baltimore); 2018 Feb; 97(7):e9856. PubMed ID: 29443749
[TBL] [Abstract][Full Text] [Related]
18. PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
Guberina M; Poettgen C; Metzenmacher M; Wiesweg M; Schuler M; Aigner C; Ploenes T; Umutlu L; Gauler T; Darwiche K; Stamatis G; Theegarten D; Hautzel H; Jentzen W; Guberina N; Herrmann K; Eberhardt WEE; Stuschke M
J Nucl Med; 2021 May; 62(12):1684-91. PubMed ID: 34016730
[No Abstract] [Full Text] [Related]
19. Prognostic value of pre-treatment
Aktan M; Kanyilmaz G; Yavuz BB; Koc M; Eryılmaz MA; Adli M
Radiol Med; 2017 Nov; ():. PubMed ID: 29177728
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study.
Kumari S; Karikios D; Yeghiaian-Alvandi R; Flynn P; Morgan L; Kay L; Ding P
Asia Pac J Clin Oncol; 2024 Feb; 20(1):25-31. PubMed ID: 36722413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
